KemPharm, Inc KMPH

CryptoFundManager Premium

When most of the companies are diluting their shares and insiders are selling, KemPharm, Inc. (KMPH) does the opposite. Insiders are buying and the Board of Directors authorizes a program to repurchase up to $50 million of the Company’s outstanding stock valid through December 31, 2023. It is equivalent to 18% of KemPharm’s current market capitalization. Because...

JetEquities

KMPH: KemPharm 2021-12-20 07:30:00 KemPharm, Inc. Announces Authorization of $50 Million Share Repurchase Program

Investor4321 Pro

KemPharm shares ( NASDAQ:KMPH ) have pulled back to a 50% retracement with an impulsive wave pattern. This implies that a corrective wave is coming up. I am targeting the $13 zone here since that happens to be the 50% retracement of this pullback and a level of previous support. Good Luck!

xxtamedtacoxx7

Bullish

follow_the_money Pro

Bullish harmonic. Pattern in combination of low float stock such as KMPH is very bullish setup especially since the stock has been hovering around previous highest volume day of 1M shares traded. the stock has been hovering around 900k and reluctant to break 1M but the tutes are getting anxious as investor Samuel Braun decided to add to his position and steal...

follow_the_money Pro

Recently approved ADHD med. CEO Travis Mickle helped develop current market leader Vyvance (also ADHD med) and now with a new and improved iteration (Aztrazyris) . Also worth to note Mickle sold his previous company (new river) to shire then shire was bought out by Takeda for bucku bucks and now Mickle is working with ex-shire CEO to bring this baby to market!...

00:00

CobraTrader13

My watchlist for this week: FDA Hype $ACAD $AVEO Swings $RKDA $APRE $ATOS $SBBP $KMPH Like and follow for more :) Happy Trading!

GodOfThund3r

Floor 8.9-9.0 and breaking down trend

BigDipNick

It seems to me that all of the shorter term EMA's are charting into a descending, converging triangle. The tipping point target is right around the current closing price of $10.62. I believe tomorrow, 3/23 will be a very big day in deciding the short term value for KMPH. It appears to be a great long term hold for people that have the time. As far as day trading...

jpactor Premium

I'm very bullish on this and long in the position. The Reddit WSB are starting to get behind it and I'm seeing more buying on the tape in large volume than selling. Shorts are in a bad place. Could see 20.00, 60.00, 90.00, or 120.00 conservatively due to very small float compared to the floats of GME or AMC. Full disclosure I'm am long this stock and have been...

Michael_6ivenchy

Bullish

jpactor Premium

I brought up this idea on WSBN discord about a week ago and I think it's starting to line up. Just as GME was a heavily shorted stock so has been KMPH with a 71% short interest as of yesterday. The company has a major catalyst with an FDA approved ADHD drug that is better than anything else out there on the market. Having ADHD I have been very interested in this...

CryptoFundManager Premium

Target 1: $29 Target 2: $45 Target 3: $80 If you are interested to test some amazing BUY and SELL INDICATORS which give the signal at the beginning of the candle, not at the end of it, just leave me a message.

AlenCiken

KemPharm Announces FDA Approval of AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsules, for oral use, CII), A New Once-Daily Treatment for ADHD Corium, Inc. will lead the commercialization of AZSTARYS per the definitive collaboration and license agreement. Corium expects to make AZSTARYS commercially available in the U.S. as early as the second...

Hiddenharmonicstrading Pro+

See chart for 618% bounce, stop below gap for more risk

trilliondollar

FDA approval with potential short squeeze. Without these catalyst the market cap still suggests that it is undervalued with the new addressable market of KP415/AZSTARYS

jahoozy

This week KMPH is awaiting FDA approval, expect catalyst to come to drive price up Buy at dips to expect pop Be mindful of bearish momentum as of recently Something like that

BDRTrigger33

$KMPH has very weak support and could retrace much lower regions in near completion of a head and shoulders formation. All signs are grossly bearish, including many large-scale sell orders having been placed in the last five days. The bigger investors have pulled the rug-- Target new entries much lower on this position if possible. Best, BDR